Supply Chain

While a two-pack of EpiPens has a list price of $608 in the U.S., Mylan sells a similar set of epinephrine auto-injectors in Britain for just $69, according to Bloomberg.

Uber already upended the taxi industry with its app that links passengers who need a ride to drivers willing to give one. Now, the company wants to do the same thing to freight brokers by developing technology that can more…

Thousand Oaks, Calif.-based Amgen will purchase a 4.5 percent stake in Arrowhead Pharmaceuticals and work with the Pasadena, Calif.-based drugmaker to develop gene-silencing drugs to treat heart disease.

Despite repeated warnings from CMS about the misclassification of EpiPens, Mylan still fails to pay the agency millions of dollars in rebates from EpiPen sales, reported CNBC.

While Bentonville, Ark.-based Wal-Mart already enforces strict guidelines for shipping time frames and delivery compliance, its suppliers will be held to even higher expectations in 2017, according to Supply Chain Brain.

The Food and Drug Administration recently approved the FreeStyle Libre Pro system, a continuous glucose monitoring system developed by Abbott Park, Ill.-based Abbott.

The Food and Drug Administration approved expanded use of Vertex Pharmaceuticals' cystic fibrosis drug Orkambi.

The Food and Drug Administration approved one of the first automated insulin delivery systems, created by Dublin, Ireland-based Medtronic. The device replicates the functions of the pancreas and is meant to help those with type 1 diabetes, according to U.S.…

The Conference Board's consumer-confidence index defied analyst expectations for September, reaching a figure that hasn't been seen since 2007, reported The Wall Street Journal.

More than 25 percent of cancer and hematology drug reviewers who left the Food and Drug Administration between 2001 and 2010 now work for or consult drug companies, according to a research letter published in The BMJ.